Aggrecan Antibody (Rabbit mAb) [M12J8]

Catalog No.: F5574

    Application: Reactivity:
    • Lane 1: A375
    1/

    当該製品は品切れ状态で、メールアドレスをご教示いただければ、お客様に返信いたします。

    代表番号: 045-509-1970|電子メール:sales@selleck.co.jp

    キーポイント

    WB
    SDS-PAGE の分離ゲルの推奨濃度:5%
    転写条件(ウェット): 250 mA, 180 min
    60秒以上の露光(暴露)を推奨します。

    使用情報

    Dilution
    1:1000-1:10000
    Application
    WB
    Source
    Rabbit Monoclonal Antibody
    Reactivity
    Human
    Storage Buffer
    PBS, pH 7.2+50% Glycerol+0.05% BSA+0.01% NaN3
    Storage (from the date of receipt)
    -20°C (avoid freeze-thaw cycles), 2 years
    Predicted MW Observed MW
    261 kDa 600 kDa
    *なぜ予測分子量と実際の分子量が異なるのか?
    下記の原因により、実際の分子量が予測と異なる:タンパク質の翻訳後修飾(リン酸化/糖鎖付加),スプライシングバリアント,イソフォーム,相対的な電荷,ポリマー。
    ポジティブコントロール A-375 cells (PNGaseF treated); Hs 822.T cells (PNGaseF treated); Hs 822.T cells; A-375 cells
    ネガティブコントロール Hep G2 cells

    プロトコール

    WB
    Experimental Protocol:
     
    Sample preparation
    1. Tissue: Lyse the tissue sample by adding an appropriate volume of ice-cold RIPA/NP-40 Lysis Buffer (containing Protease Inhibitor Cocktail),and homogenize the tissue at a low temperature or lyse it by sonication on ice, then incubate on ice for 30 minutes.
    2. Adherent cell: Aspirate the culture medium and wash the cells with ice-cold PBS twice. Lyse the cells by adding an appropriate volume of RIPA/NP-40 Lysis Buffer (containing Protease Inhibitor Cocktail) , sonicate to lyse the cells, and incubate on ice for 30 minutes.
    3. Suspension cell: Transfer the culture medium to a pre-cooled centrifuge tube. Centrifuge and aspirate the supernatant. Wash the cells with ice-cold PBS twice. Lyse the cells by adding an appropriate volume of RIPA/NP-40 Lysis Buffer (containing Protease Inhibitor Cocktail) , sonicate to lyse the cells, and incubate on ice for 30 minutes.
    4. Place the lysate into a pre-cooled microcentrifuge tube. Centrifuge at 4°C for 15 min. Collect the supernatant;
    5. Remove a small volume of lysate to determine the protein concentration;
    6. Combine the lysate with protein loading buffer. Boil 20 µL sample under 95-100°C for 5 min. Centrifuge for 5 min after cool down on ice.
     
    Electrophoretic separation
    1. According to the concentration of extracted protein, load appropriate amount of protein sample and marker onto SDS-PAGE gels for electrophoresis. Recommended separating gel (lower gel) concentration: 5%. Reference Table for Selecting SDS-PAGE Separation Gel Concentrations
    2. Power up 80V for 30 minutes. Then the power supply is adjusted (110 V~150 V), the Marker is observed, and the electrophoresis can be stopped when the indicator band of the predyed protein Marker where the protein is located is properly separated. (Note that the current should not be too large when electrophoresis, too large current (more than 150 mA) will cause the temperature to rise, affecting the result of running glue. If high currents cannot be avoided, an ice bath can be used to cool the bath.)
     
    Transfer membrane
    1. Take out the converter, soak the clip and consumables in the pre-cooled converter;
    2. Activate PVDF membrane with methanol for 1 min and rinse with transfer buffer;
    3. Install it in the order of "black edge of clip - sponge - filter paper - filter paper - glue -PVDF membrane - filter paper - filter paper - sponge - white edge of clip";
    4. The protein was electrotransferred to PVDF membrane. ( 0.45 µm PVDF membrane is recommended ) Reference Table for Selecting PVDF Membrane Pore Size Specifications
    Recommended conditions for wet transfer: 250 mA, 180 min.
    ( Note that the transfer conditions can be adjusted according to the protein size. For high-molecular-weight proteins, a higher current and longer transfer time are recommended. However, ensure that the transfer tank remains at a low temperature to prevent gel melting.)
     
    Block
    1. After electrotransfer, wash the film with TBST at room temperature for 5 minutes;
    2. Incubate the film in the blocking solution for 1 hour at room temperature;
    3. Wash the film with TBST for 3 times, 5 minutes each time.
     
    Antibody incubation
    1. Use 5% skim milk powder to prepare the primary antibody working liquid (recommended dilution ratio for primary antibody 1:1000), gently shake and incubate with the film at 4°C overnight;
    2. Wash the film with TBST 3 times, 5 minutes each time;
    3. Add the secondary antibody to the blocking solution and incubate with the film gently at room temperature for 1 hour;
    4. After incubation, wash the film with TBST 3 times for 5 minutes each time.
     
    Antibody staining
    1. Add the prepared ECL luminescent substrate (or select other color developing substrate according to the second antibody) and mix evenly;
    2. Incubate with the film for 1 minute, remove excess substrate (keep the film moist), wrap with plastic film, and expose in the imaging system. (Exposure time of at least 60s is recommended)

    Datasheet & SDS

    生物学的記述

    Specificity
    Aggrecan Antibody (Rabbit mAb) [M12J8] detects endogenous levels of total Aggrecan protein.
    タンパク質の局在
    細胞外マトリックス、細胞外環境
    Uniprot ID
    P16112
    Clone
    M12J8
    Synonym(s)
    ACAN, AGC1, AGCAN, aggrecan, Aggrecan core protein, Aggrecan core protein 2, CSPCP, CSPG1, CSPGCP, large aggregating proteoglycan, MSK16, PGCA, SEDK, SSOAOD
    Background
    Aggrecan, encoded by ACAN, is a large chondroitin sulfate proteoglycan of the lectican family that is highly expressed in growth plate and articular cartilage and forms a major non‑collagenous structural component of the cartilage extracellular matrix together with type II collagen. The core protein contains three globular domains (G1, G2, G3) separated by extended regions bearing dense arrays of chondroitin sulfate and keratan sulfate chains; the N‑terminal G1 domain, which shares structural motifs with link protein, binds hyaluronan and link protein to form large ternary aggregates, the central G2 domain is homologous to G1/link repeats and contributes to product processing, and the C‑terminal G3 domain regulates glycosaminoglycan modification, secretion, and interactions with other matrix molecules. The glycosaminoglycan‑rich domain between G2 and G3 carries multiple chondroitin sulfate and keratan sulfate chains that create a highly negatively charged, bottlebrush‑like polyelectrolyte, and aggrecan–hyaluronan aggregates embedded in the collagen network form a hydrated gel that imbibes water, generates swelling pressure, and provides the osmotic and mechanical properties required for cartilage to resist compressive loads during joint use. Through hyaluronan‑dependent aggregation and interactions of its G3 domain with ECM partners such as tenascins, fibulins, and fibrillin, aggrecan organizes the pericellular and territorial matrix and contributes to chondrocyte–matrix and chondrocyte–chondrocyte interactions that influence chondroskeletal morphogenesis in development and maintenance of articular cartilage architecture in maturity. In the central nervous system, aggrecan is present in perineuronal nets where it binds hyaluronan, link protein, and tenascins to form condensed ECM structures around neurons, and in this context it regulates the organization of neural extracellular space and contributes to control of developmental plasticity and responses to injury. ACAN mutations that alter core protein structure or glycosaminoglycan attachment associate with short stature, skeletal dysplasia, and abnormal joint and spine development, consistent with a central role of aggrecan in growth plate function and cartilage patterning. In osteoarthritis and related degenerative joint diseases, aggrecan loss from cartilage is an early and prominent event, and cleavage of the core protein by aggrecanases such as ADAMTS‑4 and ADAMTS‑5, and by matrix metalloproteinases, generates defined fragments that diffuse from the tissue and reduce proteoglycan content, leading to diminished load‑bearing capacity and altered cartilage biomechanics.
    References

    技術サポート

    ストックの作り方、阻害剤の保管方法、細胞実験や動物実験の際に注意すべき点など、製品を取扱う時に問い合わせが多かった質問に対しては取扱説明書でお答えしています。

    Handling Instructions

    他に質問がある場合は、お気軽にお問い合わせください。

    * 必須

    大学・企業名を記入してください
    名前を記入してください
    電子メール・アドレスを記入してください 有効なメールアドレスを入力してください
    お問い合わせ内容をご入力ください